Amplifier

Instruction for Use

Quick Cup 25 Tests/kit

The FeNObreath is a portable, non-invasive device for the measurement of Fractional Exhaled Nitric Oxide (FeNO) in human breath. The production of nitric oxide is often found to be increased in inflammatory conditions such as asthma. Measurement of FeNO by FeNObreath is a method to measure the decrease in FeNO concentration in asthma patients that often occurs after treatment with anti-inflammatory pharmacological therapy, as an indication of the therapeutic effect in patients with elevated FeNO levels.The fractional NO concentration in expired breath (FeNO), can be measured by FeNObreath according to guidelines for NO measurement established by the American Thoracic Society.FeNObreath is intended for children, 7- 17 years, and adults 18 years and older. FeNObreath 12 second test mode is for age 7 and upFeNObreath 10 second test mode is for ages 7-10 only who cannot successfully complete a 12 second test.FeNO measurements provide the physician with means of evaluating an asthma patient's response to anti-inflammatory therapy, as an adjunct to the established clinical and laboratory assessments in asthma. The FeNObreath cannot be used with infants or by children under the age of 7 as measurement requires patient cooperation.FeNObreath should not be used in critical care, emergency care or in anesthesiology.

The NObreath® is a portable, non-invasive device for the measurement of Fractional Exhaled Nitric Oxide (FeNO) in human breath. The production of nitric oxide is often found to be increased in inflammatory conditions such as asthma. Measurement of FeNO by NObreath® is a method to measure the decrease in FeNO concentration in asthma patients that often occurs after treatment with anti-inflammatory pharmacological therapy, as an indication of the therapeutic effect in patients with elevated FeNO levels.The fractional NO concentration in expired breath (FeNO), can be measured by NObreath® according to guidelines for NO measurement established by the American Thoracic Society.NObreath® is intended for children, 7- 17 years, and adults 18 years and older. NObreath® 12 second test mode is for age 7 and upNObreath® 10 second test mode is for ages 7-10 only who cannot successfully complete a 12 second test.FeNO measurements provide the physician with means of evaluating an asthma patient's response to anti-inflammatory therapy, as an adjunct to the established clinical and laboratory assessments in asthma. The NObreath® cannot be used with infants or by children under the age of 7 as measurement requires patient cooperation.NObreath® should not be used in critical care, emergency care or in anesthesiology.

Drugs of Abuse Negative Calibrator 1 X 15 mL

Drugs of Abuse Low Calibrator 1 X 15 mL

Drugs of Abuse Cutoff Calibrator 1 X 15 mL

Drugs of Abuse Intermediate Calibrator 1 X 15 mL

Drugs of Abuse High Calibrator 1 X 15 mL

Drugs of Abuse Level 1 Control 1 X 15 mL

Drugs of Abuse Level 2 Control 1 X 15 mL

Multi-Analyte DAU Calibrator Kit 4 X 15 mL

Multi-Analyte DAU Control Kit 4 X 15 mL

The paracetamol test system is intended for the quantitative in vitro determination of Acetaminophen in human serum.

The Randox Benzodiazepines Calibrator Set is intended for use in the calibration of the Benzodiazepines assay. The Calibrator Set contains 5 levels of calibrator containing the specific drug Oxazepam.

The Randox Benzodiazepines Control Level 1 is intended for use in the Quality Control of the Benzodiazepines (BENZ) assay. The Benzodiazepine Control Level 1 contains the specific drug Oxazepam.

The Randox Benzodiazepines Control Level 2 is intended for use in the Quality Control of the Benzodiazepines (BENZ) assay. The Benzodiazepine Control Level 2 contains the specific drug Oxazepam.

The Methamphetamine assay is an in vitro diagnostic test for the qualitative and semi-quantitative detection of methamphetamine in human urine.

The Barbiturates assay is an in vitro diagnostic test for the qualitative and semi-quantitative detection of Barbiturates in human urine.

The Benzodiazepine assay is an in vitro diagnostic test for the qualitative and semi-quantitative detection of Benzodiazepines in human urine

The Cannabinoid assay is an in vitro diagnostic reagent for the qualitative and semi-quantitative analysis of Cannabinoids (THC) in human urine.

The Cocaine assay is an in vitro diagnostic test for the qualitative and semi-quantitative detection of benzoylecgonine (Cocaine Metabolite) in human urine.

The Opiates assay is an in vitro diagnostic test for the qualitative and semi-quantitative detection of Opiates in human urine.

The EDDP assay is an in vitro diagnostic test for the qualitative and semi-quantitative detection of 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP) in human urine.

The MDMA assay is an in vitro diagnostic reagent. For the qualitative and semi-quantitative analysis of MDMA in human urine.

The ethanol assay is an in vitro diagnostic test for the quantitative analysis of ethanol in human urine and serum.

The Methadone assay is an in vitro diagnostic test for the qualitative and semi-quantitative detection of methadone in human urine.

The product is intended for the quantitative in vitro determination of Lithium in serum.

Therapeutic Drug Markers (TDM) Linearity Verifiers are an in vitro diagnostic product used to assess the linearity of the Roche Systems for Acetaminophen, Amikacin, Carbamazepine, Digoxin, Gentamicin, Lithium, N-Acetylprocainamide, Phenobarbital, Phenytoin, Procainamide, Quinidine, Salicylate, Theophylline, Tobramycin, Valproic Acid and Vancomycin assays.

For the quantitative in vitro determination of Salicylate in human serum